MicroRNA-429 inhibits bone metastasis in breast cancer by regulating CrkL and MMP-9
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Beijing Municipality
This publication has 51 references indexed in Scilit:
- The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and TreatmentJournal of Clinical Medicine, 2013
- Crk adaptor proteins act as key signaling integrators for breast tumorigenesisBreast Cancer Research, 2012
- Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trialThe Lancet, 2012
- Implications of Bone-Only Metastases in Breast Cancer: Favorable Preference with Excellent Outcomes of Hormone Receptor Positive Breast CancerCancer Research and Treatment, 2011
- Breast cancer metastasis to the bone: mechanisms of bone lossBreast Cancer Research, 2010
- Emerging Roles for Crk in Human CancerGenes & Cancer, 2010
- AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone massBone, 2010
- Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancerOncogene, 2009
- Functions of RANKL/RANK/OPG in bone modeling and remodelingArchives of Biochemistry and Biophysics, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001